Back to Markets
CGCognition Therapeutics Inc

Cognition Therapeutics Inc

CGTX
Health CareBiotechnology: Biological Products (No Diagnostic Substances)

$1.25

+0.0700 (+5.93%)

As of 4:00 PM EDT · USD

Compare
Low: $0.2400Current: $1.25High: $3.83

Key Statistics

Open

$1.17

Day High

$1.38

Day Low

$1.16

Prev. Close

$1.18

VolumeShares traded today.

2.39M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$111.87M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-4.85

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$3.83

52W LowLowest price over the past 52 weeks.

$0.2400

50D MAAverage closing price over the last 50 trading days.

$1.11

200D MAAverage closing price over the last 200 trading days.

$1.44

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

-5.6%

1M

+0.0%

6M

-19.2%

YTD

-19.7%

1Y

+272.2%

About

TCA Venture Group is an American provider of venture capital to early-stage companies in Southern California. In 2023, TCA had about 400 members. In August 2014, an analysis by CB Insights ranked TCA No.1 out of 370 angel groups on “Network Centrality” and No. 5 overall in “Investor Mosaic.”

Company Facts

SectorHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade CGTX

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.